Report: The Impact of COVID-19 on Pegfilgrastim Biosimilar Market, Projected Fact.MR

Dubai, UAE -- (SBWIRE) -- 11/24/2020 -- The pegfilgrastim biosimilar market is projected to register considerable growth in between 2020 and 2026. A Fact.MR study shows that coronavirus outbreak has deterred the opportunities in the market for a short term. Wide ranging field of applications in HIV/AIDS will also help in sustaining better growth for years to come.